Department of Neurological Surgery.
Department of Orthopedic Surgery.
Clin Spine Surg. 2023 Jul 1;36(6):E226-E233. doi: 10.1097/BSD.0000000000001399. Epub 2022 Oct 10.
Retrospective cohort study.
To evaluate the association of Hemoglobin A1C (HbA1c) with surgical site infection (SSI) and patient-reported outcomes (PROs), and to identify optimal HbA1c thresholds to minimize the risk of SSI and maximize PROs.
Diabetes mellitus has been associated with worsened outcomes following spine surgery. HbA1c, a surrogate of glycemic control, is an important assessment tool in diabetic patients.
A single-center, retrospective cohort study using prospectively collected data was undertaken. Diabetic patients undergoing elective lumbar decompression surgery between October 2010 and May 2021 were included. HbA1c, demographics, comorbidities, and perioperative data were collected. Primary outcomes included: 1) SSI, and 2) PROs, including the Numeric Rating Scale (NRS)-back/leg pain and Oswestry Disability Index (ODI). Secondary outcomes included: complications, readmissions, and reoperations within 90-days postoperatively. The minimum clinically important difference (MCID) was set at a 30% improvement from baseline PROs.
Of 1819 patients who underwent lumbar decompression surgery, 368 patients had diabetes mellitus, and 177 had a documented preoperative HbA1c value. Of patients with available HbA1c values, the mean age was 62.5±12.3, the mean HbA1c value was 7.2±1.5%, and SSI occurred in 3 (1.7%) patients only, which prevented further analysis of SSI and HbA1c. A significant association was seen with a higher HbA1c and failure to achieve NRS-Back pain MCID30 [Odds ratio(OR)=0.53, 95% confidence interval(CI) 0.42-0.78; P =0.001] and ODI MCID30 (OR=0.58, 95%CI 0.44-0.77; P =0.001), but not NRS-Leg pain MCID30 (OR=1.29, 95%CI 0.86-1.93; P =0.208). ROC-curve analysis and Youden's index revealed an HbA1c threshold of 7.8 for NRS-Back pain MCID30 (AUC=0.65, P <0.001) and 7.5 for ODI MCID30 (AUC=0.65, P =0.001).
In diabetic patients undergoing elective lumbar decompression surgery, HbA1c levels above 7.8 and 7.5 were associated with less improvement of NRS-Back and ODI scores at 12-months postoperatively, respectively. To optimize PROs, We recommend a preoperative HbA1c of 7.5 or below for diabetic patients undergoing elective lumbar decompression surgery.
回顾性队列研究。
评估糖化血红蛋白(HbA1c)与手术部位感染(SSI)和患者报告的结果(PROs)之间的关联,并确定最佳的 HbA1c 阈值,以最大限度地降低 SSI 风险并优化 PROs。
糖尿病与脊柱手术后的预后恶化有关。HbA1c 是血糖控制的替代指标,是糖尿病患者的重要评估工具。
采用前瞻性收集数据的单中心回顾性队列研究。纳入 2010 年 10 月至 2021 年 5 月期间接受择期腰椎减压手术的糖尿病患者。收集 HbA1c、人口统计学、合并症和围手术期数据。主要结局包括:1)SSI,2)PROs,包括数字评分量表(NRS)-腰背疼痛和 Oswestry 残疾指数(ODI)。次要结局包括:术后 90 天内的并发症、再入院和再次手术。最小临床重要差异(MCID)设定为 PROs 基线改善 30%。
在 1819 例接受腰椎减压手术的患者中,368 例患有糖尿病,177 例有术前 HbA1c 值记录。在有可用 HbA1c 值的患者中,平均年龄为 62.5±12.3 岁,平均 HbA1c 值为 7.2±1.5%,仅有 3 例(1.7%)患者发生 SSI,这阻止了对 SSI 和 HbA1c 进一步分析。HbA1c 值较高与 NRS-腰背疼痛 MCID30 未能达标显著相关[比值比(OR)=0.53,95%置信区间(CI)0.42-0.78;P=0.001]和 ODI MCID30(OR=0.58,95%CI 0.44-0.77;P=0.001),但与 NRS-腿部疼痛 MCID30 无关(OR=1.29,95%CI 0.86-1.93;P=0.208)。ROC 曲线分析和 Youden 指数显示,HbA1c 阈值为 7.8 时与 NRS-腰背疼痛 MCID30 相关(AUC=0.65,P<0.001),HbA1c 阈值为 7.5 时与 ODI MCID30 相关(AUC=0.65,P=0.001)。
在接受择期腰椎减压手术的糖尿病患者中,HbA1c 水平高于 7.8 和 7.5 分别与术后 12 个月 NRS-腰背和 ODI 评分改善较少相关。为了优化 PROs,我们建议择期腰椎减压手术的糖尿病患者术前 HbA1c 应控制在 7.5 以下。